FDA WARNING | INSOMNIA MEDICINES – INCLUDING AMBIEN, LUNESTA, AND SONATA – LINKED TO SERIOUS SLEEPWALKING INJURIES
The FDA issued a black-box warning on April 30, 2019 for the following medications:
- Lunesta (eszopiclone)
- Sonata (zaleplon)
- Ambien or Ambien CR (zolpidem)
- Edluar (zolpidem)
- Intermezzo (zolpidem)
- Zolpimist (zolpidem)
This warning comes following reports that patients experienced serious injuries resulting from sleep behaviors, including sleepwalking, sleep driving, and engaging in other activities while not fully awake. These complex sleep behaviors have also resulted in deaths. If you or a family member has been prescribed one of these insomnia medicines and were injured while sleepwalking, we would like to hear about your experience. Fill out our free case review form or call us at 1.800.755.0098 to learn more.
Read the FDA’s Drug Safety Communication here.
Based on reports filed with the FDA and others reports in medical literature, patients who were prescribed these medications have suffered serious injuries, including death. The injuries while sleepwalking include:
- Exposure to extreme cold temperatures leading to loss of limb
- Carbon monoxide poisoning
- Motor vehicle collisions with the patient driving
- Self-injuries such as gunshot wounds and apparent suicide attempts
- Accidental overdoses
HOW WE CAN HELP
If you or a family member has been prescribed one of these insomnia medicines and suffered a serious injury while sleepwalking, we would like to hear about your experience. Our team is ready to evaluate your potential claims and help you navigate any next steps you want to consider. For more information, or to speak with someone about your this issue, please call us at 1.800.755.0098. Zimmerman Reed is experienced in helping individuals injured by prescription drugs and we welcome your questions.